Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Xtant Medical Holdings, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +5 vs. Q3 2021
- Shares held
- 80.7M
- +154.5K (+0.2%) vs. Q3 2021
- Total value
- $45.2M
- −$44.2M (−49.5%) vs. Q3 2021
- New holders
- 5
- 5 more added
- Sold out
- 0
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XTNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $33.8M |
| Q1 2026 | 34 | $45.1M |
| Q4 2025 | 35 | $63.8M |
| Q3 2025 | 30 | $52.0M |
| Q2 2025 | 30 | $59.1M |
| Q1 2025 | 28 | $45.3M |
| Q4 2024 | 30 | $42.8M |
| Q3 2024 | 28 | $66.1M |
| Q2 2024 | 27 | $56.7M |
| Q1 2024 | 33 | $105.7M |
| Q4 2023 | 31 | $101.9M |
| Q3 2023 | 28 | $99.3M |
| Q2 2023 | 19 | $76.0M |
| Q1 2023 | 21 | $52.2M |
| Q4 2022 | 19 | $54.1M |
| Q3 2022 | 18 | $58.8M |
| Q2 2022 | 18 | $41.9M |
| Q1 2022 | 19 | $54.8M |
| Q4 2021 | 22 | $45.2M |
| Q3 2021 | 17 | $89.4M |
| Q2 2021 | 20 | $134.8M |
| Q1 2021 | 21 | $175.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Xtant Medical Holdings, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 73 | $0 | 0.00% | +26+55.3% | Added |
| Wells Fargo & Company | 85 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 30 | $0 | 0.00% | +1+3.4% | Added |
| Advisor Group Holdings, Inc. | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Outfitter Financial LLC | 1,177 | $1.00K | 0.00% | +1,177 | New |
| Tower Research Capital LLC (TRC) | 10,269 | $6.00K | 0.00% | −21,393−67.6% | Reduced |
| HRT Financial LP | 12,812 | $7.00K | 0.00% | −7,257−36.2% | Reduced |
| Victory Capital Management Inc | 12,501 | $7.00K | 0.00% | −375−2.9% | Reduced |
| Susquehanna International Group, LLP | 13,867 | $8.00K | 0.00% | +13,867 | New |
| Geode Capital Management, LLC | 21,204 | $11.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,800 | $13.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 23,083 | $13.0K | 0.00% | +610+2.7% | Added |
| Two Sigma Securities, LLC | 22,958 | $13.0K | 0.00% | +22,958 | New |
| Vanguard Group Inc | 44,170 | $25.0K | 0.00% | −4,066−8.4% | Reduced |
| UBS Group AG | 44,720 | $25.0K | 0.00% | +44,720 | New |
| Virtu Financial LLC | 58,037 | $33.0K | 0.00% | +33,438+135.9% | Added |
| Crescent Grove Advisors, LLC | 162,024 | $91.0K | 0.01% | +162,024 | New |
| Bridgeway Capital Management, LLC | 372,000 | $208.0K | 0.00% | −123,900−25.0% | Reduced |
| Renaissance Technologies LLC | 721,600 | $404.0K | 0.00% | +40,800+6.0% | Added |
| Altium Capital Management LP | 6,246,291 | $3.50M | 0.98% | −8,167−0.1% | Reduced |
| OrbiMed Advisors LLC | 72,873,494 | $40.8M | 0.53% | 00.0% | Unchanged |